Clinical Trials Directory

Trials / Completed

CompletedNCT03032770

Early Prediction of Placenta Accreta by Ultrasound and Color Doppler

Early Prediction of Placenta Accreta by 2 Dimensional Transvaginal Ultrasound and Color Doppler

Status
Completed
Phase
Study type
Observational
Enrollment
148 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Placenta accreta is a substantially life threatening condition and one of the causes of maternal morbidity and mortality in the world. According to study done in United Kingdom, The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall and 577 per 10,000 in women with both a previous cesarean delivery and placenta previa. in a tertiary south Italian center, The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s.While in United States of America, the prevalence of placenta accreta was 3.7 per 1000 deliveries.

Conditions

Interventions

TypeNameDescription
DEVICEtwo-dimensional ultrasound and color Dopplerthe eligible participants will be searched for signs suggestive of placenta accreta; low implantation of the gestational sac (\<4cm from the external os), presence of placental lakes, Disruption of placental-myometrial interface and trophoblast overlapping a uterine scar by 2 dimensional transvaginal ultrasound and Intraplacental dilated vessels, turbulent blood flows and greatly increased periplacental vascularity by Doppler ultrasound by level II sonographer and co-investigator under his supervision using ultrasound device.

Timeline

Start date
2017-01-01
Primary completion
2019-12-31
Completion
2020-03-31
First posted
2017-01-26
Last updated
2020-05-13

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT03032770. Inclusion in this directory is not an endorsement.

Early Prediction of Placenta Accreta by Ultrasound and Color Doppler (NCT03032770) · Clinical Trials Directory